sulfasalazine has been researched along with Harelip in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Källén, B | 1 |
| Craxi, A | 1 |
| Pagliarello, F | 1 |
| Amitai, Y | 1 |
| Leventhal, A | 1 |
3 other studies available for sulfasalazine and Harelip
| Article | Year |
|---|---|
Maternal drug use and infant cleft lip/palate with special reference to corticoids.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Cleft Lip; Cl | 2003 |
Possible embryotoxicity of sulfasalazine.
Topics: Abnormalities, Drug-Induced; Cleft Lip; Cleft Palate; Colitis, Ulcerative; Female; Humans; Hydroceph | 1980 |
Folic acid antagonists during pregnancy and risk of birth defects.
Topics: Abnormalities, Drug-Induced; Cleft Lip; Female; Folic Acid Antagonists; Heart Defects, Congenital; H | 2001 |